| Schedule of Basic and Diluted Net (Loss) Income Per Share |
The following table sets forth the computation of basic and diluted net loss per share: | | | | | | | | | | | | | | | | | | | | | | | | | (In thousands, except for share and per share amounts) | Three Months Ended
June 30, | | Six Months Ended
June 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Numerator: | | | | | | | | Net loss attributable to common stockholders—Basic | $ | (12,747) | | $ | (19,499) | | $ | (39,188) | | $ | (33,412) | Net loss attributable to common stockholders—Diluted | $ | (12,747) | | $ | (19,499) | | $ | (39,188) | | $ | (33,412) | | Denominator: | | | | | | | | Weighted-average common shares outstanding—Basic (1) | 147,811,114 | | 143,004,474 | | 147,071,137 | | 142,398,476 | | | | | | | | | | | | | | | | | Weighted-average common shares outstanding—Diluted (1) | 147,811,114 | | 143,004,474 | | 147,071,137 | | 142,398,476 | | | | | | | | | Net loss per share—Basic | $ | (0.09) | | $ | (0.14) | | $ | (0.27) | | $ | (0.23) | Net loss per share—Diluted | $ | (0.09) | | $ | (0.14) | | $ | (0.27) | | $ | (0.23) |
(1)Excludes weighted-average Sponsor Vesting Shares subject to return of 3,000,000 shares for each of the three and six months ended June 30, 2025 and 4,500,000 shares for each of the three and six months ended June 30, 2024.
|
| Schedule of Potentially Dilutive Securities for Common Stock |
The following potentially dilutive securities for common stock were outstanding and excluded from diluted net loss per share as they are subject to performance or market conditions that were not achieved as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Options to purchase common stock | 1,058,231 | | | 1,481,531 | | | 1,058,231 | | | 1,481,531 | | | Performance-based stock awards | 1,951,788 | | | 1,780,168 | | | 1,951,788 | | | 1,780,168 | | | Earnout shares | 25,000,000 | | | 25,000,000 | | | 25,000,000 | | | 25,000,000 | | Sponsor Vesting Shares | 3,000,000 | | | 4,500,000 | | | 3,000,000 | | | 4,500,000 | |
The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Options to purchase common stock | 2,670,824 | | | 2,881,767 | | | 2,670,824 | | | 2,881,767 | | | Warrants to purchase common stock | 35,476,627 | | | 35,476,627 | | | 35,476,627 | | | 35,476,627 | | | | | | | | | | | | | | | | | | | RSU awards | 13,535,045 | | | 11,311,784 | | | 13,535,045 | | | 11,311,784 | |
|